New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, with the market forecast to reach USD 60.53 billion by 2030. Even so, widely used treatments such as GLP-1 receptor agonists (GLP-1RAs) still come with well-known tradeoffs. Patients […]
Source link